CABEI makes second disbursement of US$5.8 million for the purchase of COVID-19 vaccines in Honduras
With the Bank's first disbursement, more than 238,000 doses have entered the country and 90% of them have already been applied, benefiting more than 106,000 people in the population groups over 60 years of age, people with disabilities and essential workers.
Tegucigalpa, August 24, 2021.- This Tuesday, the Central American Bank for Economic Integration (CABEI) made the second disbursement of US$5.8 million of the loan signed with the Republic of Honduras to support the implementation of the National Plan for the Introduction of the COVID-19 Vaccine, with which the purchase of 4.4 million doses is foreseen for the immunization of 2.2 million Hondurans.
CABEI Executive President, Dr. Dante Mossi, highlighted, "We are pleased with the progress made by the Health Ministry in the purchase of vaccines and the implementation of the Plan, since with this financing we are contributing to the immunization of more than 30% of Hondurans prioritized by the authorities. CABEI, as the Bank of Central Americans, will continue to support the countries in their efforts to combat the pandemic.
In May, CABEI and Honduras formalized financing of US$35 million from CABEI's COVID-19 Emergency Support and Preparedness and Economic Reactivation Program, which CABEI made available to its member countries for up to US$800 million on very favorable terms.
Honduras was the second country to make the request, and in June the first disbursement of US$7 million was made, resulting in the purchase of 238,000 doses for the benefit of more than 106,000 Hondurans.
This initiative is in line with CABEI's 2020-2024 Institutional Strategy and its Human Development and Social Inclusion strategic axis, which seeks to guarantee the well-being and quality of life of Central Americans.
